Search Results 161-170 of 17291 for egfr

1. Genetic Testing in Screening Patients with Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial) - Mayo Clinic

   No prior treatment with agents targeting EGFR mutation or ALK rearrangement; Non ... EGFR and ALK. In order to allow for time for central genotyping and ...

2. A Study to Evaluate DS-1062a Combined with Pembrolizumab in Advanced or Metastatic Non-Small Cell Lung Cancer Without Actionable Genomic Alterations - Mayo Clinic

   ... EGFR and ALK genomic alterations. Participants with squamous histology are required to undergo testing for EGFR and ALK genomic alterations if they are ...

3. A Study of a Personalized Cancer Vaccine Targeting Shared Neoantigens - Mayo Clinic

   MSS-CRC who are currently receiving systemic treatment with a fluoropyrimidine and oxaliplatin and/or irinotecan that may include a VEGF or EGFR targeting ...

4. Publications - Umair Majeed, M.B.B.S., M.D. - Mayo Clinic

   EGFR/ERBB2 Amplifications and Alterations Associated With Resistance to Lenvatinib in Hepatocellular Carcinoma. Gastroenterology 2023 May; 164 (6):1006-1008 ...

5. A Master Screening Protocol For Previously-Treated Non-Small Cell Lung Cancer - Mayo Clinic

   Patients with known EGFR sensitizing mutations, EGFR T790M mutation, ALK gene fusion, ROS 1 gene rearrangement, or BRAF V600E mutation are not eligible ...

6. Enhancing the Natriuretic Peptide System in HFpEF - Mayo Clinic

   * Glomerular filtration rate (eGFR) of \> 50 mL/min/1.73 m\^2 as estimated by the Modification of Diet in Renal Disease equation. In addition to the ...

7. A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease - Mayo Clinic

   eGFR greater than or equal to 20 and less than 30 mL/min/1.73m², not requiring renal dialysis. UACR level cannot exceed 5000 mg/g (565 mg/mmol) OR: eGFR of ...

8. End-stage kidney disease - Symptoms and causes - Mayo Clinic

   When kidney disease becomes very advanced and kidneys no longer work well enough to meet your body's needs, treatment involves kidney dialysis or kidney ...

9. Low-grade UTUC Treated with Nadofaragene Firadenovec Administered to Renal Pelvis - Mayo Clinic

   Have an estimated glomerular filtration rate (eGFR) ≥45 mL/min/1.73 m2 (for inclusion in the safety lead-in the eGFR must be ≥60 mL/min/1.73 m2 \[see ...

10. Study Of DISC-0974 To Assess The Safety, Tolerability, PK And PD Of DISC-0974 In Participants With CKD And Anemia - Mayo Clinic

    Aged ≥ 18 years of age at the time of signing informed consent. 2. Non-dialysis dependent chronic kidney disease, stages 2-5, defined as eGFR < 90mL/min/1.73m2 ...